This approach incorporates βA, tau and p-tau detection in cerebrospinal fluid and in neuroimaging markers (MRI, functional MRI, PET), defining the ATN (A: amyloid; T: tau; N: neurodegeneration marks) classification of biological AD [19], recently modified for another more complex construct [127]. Here, MAPT is linked to Alzheimer disease.